Evidence map›Paper›PMID 25568533›Full record

Trial reportMedical archives (Sarajevo, Bosnia and Herzegovina)2014

Clinical Effects of Portulaca Oleracea Seeds on Dyslipidemia in Obese Adolescents: a Triple-blinded Randomized Controlled Trial.

Ali Mohammad Sabzghabaee, Roya Kelishadi, Hadi Jelokhanian, Sedigheh Asgary, Alireza Ghannadi, Shirinsadat Badri

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Medical archives (Sarajevo, Bosnia and Herzegovina), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Review
  3. The Use of Complementary and Alternative Treatments in Adolescent Obesity: A Narrative Review.International journal of environmental research and public health · 2025
    Review
  4. Frontiers in pharmacology · 2024
    Article
  5. Review
  6. Effects ofIranian journal of basic medical sciences · 2022
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ali Mohammad SabzghabaeeIsfahan Clinical Toxicology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Roya KelishadiIsfahan Cardiovascular Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Hadi JelokhanianChild Growth and Development Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Sedigheh AsgaryIsfahan Cardiovascular Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Alireza GhannadiIsfahan Pharmaceutical Sciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Shirinsadat BadriDepartment of Clinical Pharmacy and Pharmacy Practice, Isfahan University of Medical Sciences, Isfahan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveChildhood obesity is a major public health concern worldwide while the current epidemic may be secondary to over consumption of high-fat, energy-rich foods. Purslane (Portulaca oleracea L.) has been traditionally used in medicine for several antioxidant and anti-atherogenic activities. In this study the anti-dyslipidemic effects of P.oleracea was evaluated in obese adolescents.

methodsIn this triple-blinded randomized placebo-controlled clinical trial which was done from July 2011 to June 2012, obese adolescent patients whom were referred to the Isfahan Cardiovascular Research Institute (Iran) were randomly allocated to the two arms of cases and controls. The cases group was asked to take one capsule containing powdered P. oleracea seeds (500 milligrams) two times a day for one month, and the controls group were asked to take identical but placebo (lactose) capsules in the same way. Biochemical parameters including 12-hours fasting serum levels of total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglycerides (TG) were measured before the initiation and after the completion of the study protocol.

findingsTotal cholesterol, LDL-C, and TG showed statistically significant changes over time (one month) in the P. oleracea group (p < 0.05). However, between-group analysis using general linear model (multivariate) test revealed that the differences in the mentioned parameters between two study groups were statistically significant just for LDL-C and TG, while others did not differ significantly.

conclusionP. oleracea L. may have positive effects on serum lipids profile which may be attributed to its polyphenolic and antioxidant compounds. This herbal drug seems to be well-tolerated in adolescent population as well. Further studies are recommended.

Indexed as

Anti-Obesity AgentsAntioxidantsPhytotherapyPortulacaAdolescentDyslipidemiasEpidemiologic Research DesignFemaleHumansIranLipidsMalePediatric ObesitySeedsTreatment OutcomeTriglyceridesAnti-Obesity AgentsAntioxidantsLipidsTriglyceridesadolescentclinical trialdyslipidemiaobesityPortulaca oleracea

Identifiers

PMID25568533
PMCPMC4240324

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.